Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in WASHINGTON, DC
- Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Contract Details
- Notice ID
- 75A50126R00001_RFP_NPIVS_27
- Opportunity Type
- Solicitation
- Sub-Agency
- OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
- Office
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Posted Date
- Monday, August 17, 2026
- Response Deadline
- Friday, October 30, 2026
- PSC Code
- AN12
- Set-Aside
- No Set Aside
- Place of Performance
- WASHINGTON, DC, 20515
- Status
- Active
Description
BARDA seeks Contractor(s) to support the continuation of the Vaccine Medical Counermeasures (MCM's) for Pandemic Influenza Preparedness and Response Program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (U.S. facilities preferred) not otherwise provided by the USG as needed to provide MCMs, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by BARDA; produce antigens, adjuvants, and/or vaccines to support USG efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in WASHINGTON, DC. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts